Crypto payments to unregulated peptide vendors surged 159% to $32 million in Q1 2026, continuing a six-quarter growth trend. This rise is fueled by cultural trends favoring alternative health and physical optimization, with Chinese suppliers shifting from fentanyl precursors to peptides. Stablecoins have become the preferred payment method over Bitcoin for larger transactions. However, safety concerns grow as spending on independent lab testing has dropped 88%, with major vendors relying on supplier quality assurance instead of third-party tests.
Shield Therapeutics has agreed to take full commercial control of its oral iron therapy ACCRUFeR in the US from Viatris starting September 30, without any upfront payment. Instead, Shield will pay reduced royalties on US sales over five years. This m...
Autohome reported Q2 2026 results in line with expectations but faces significant challenges due to declining auto sales and reduced dealer advertising budgets in China. Its traditional vertical advertising model is under pressure from alternative pl...
Bread Financial Holdings, formerly Alliance Data, is a U.S. financial services firm specializing in consumer payment and lending solutions. It maintains a strong financial position with a Tier 1 capital ratio near 14% and BB credit ratings, funding i...
BlackRock has purchased over $3.1 billion worth of Bitcoin and Ethereum in just eight days, acquiring 22,722 BTC and 385,633 ETH. This surge in buying coincides with a strong recovery in the broader cryptocurrency market. BlackRock's crypto funds, in...
Marvell Technology reported Q2 earnings and revenue above Wall Street expectations, with data center revenue up 46% year-over-year to $2.17 billion, driven by robust AI-related bookings. Despite this, shares fell 8% in premarket trading as investors ...
